WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: XELJANZ

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on XELJANZ

Proof of use for XELJANZ

We do not have any records of a proof of use for XELJANZ at this moment.

Click here to add a proof of use for XELJANZ

Possible trademark infringements of XELJANZ

Basic Information about XELJANZ

Serial Number
77688128
Filing Date
11 Mar 2009
Registration Number
4099367
Registration Date
14 Feb 2012
Mark Drawing Code
4

Classifications

Declare the trademark use of XELJANZ on the blockchain with WikiTrademarks.io.

First use of XELJANZ anywhere
XELJANZ was first used on 20 Oct 2011 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns XELJANZ?

1. Pfizer Inc. New York NY

2. Pfizer Inc. New York NY

3. Pfizer Inc. New York NY

Correspondent

Andrea Christensen
PFIZER INC.
66 Hudson Boulevard East
NEW YORK NY 10001-2192

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on XELJANZ